HKU Scholars Hub: Browsing DSpace

Browsing by Author Bulusu, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date	Views
	Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus Journal:Molecular Cancer Therapeutics	Liu, Y Starr, M Brady, J Rushing, C Bulusu, A Pang, HMH Honeycutt, W Amara, A Altomare, I Uronis, H	2015	65
	Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab Journal:Cancer Medicine	Liu, Y Starr, MD Bulusu, A Pang, HMH Wong, NS Honeycutt, W Amara, A Hurwitz, HI Nixon, AB	2013	61
	Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing Journal:Clinical Cancer Research	Jia, J Dellinger, A Weiss, E Bulusu, A Rushing, C Li, H Howard, L Kaplan, N Pang, HMH Hurwitz, H	2015	55
	Direct Evidence of Targeted Inhibition by Anti-angiogenic Agents from a Wound-healing Model in Patients with Advance Solid Tumors Proceeding/Conference:Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy Conference	Jia, J Dellinger, A Weiss, ES Bulusu, A Li, H Howard, L Kaplan, N Pang, HMH Hurwitz, H Nixon, AB	2014	43
	A leave-one-out cross-validation SAS macro for the identification of markers associated with survival Journal:Computers in Biology and Medicine	Rushing, C Bulusu, A Hurwitz, H Nixon, A Pang, HMH	2015	75
	Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A) Proceeding/Conference:Journal of Clinical Oncology	Nixon, A Starr, M Pang, HMH Bulusu, A Honeycutt, W Amara, A Bendell, JC Hurwitz, H	2010

Showing results 1 to 6 of 6